| 1 |
34626387 | Chemical Approaches to Prepare Modified Heparin and Heparosan Polymers for Biological Studies. | 2022 |
1 |
| 2 |
33733622 | Heparin-modified alginate microspheres enhance neovessel formation in hiPSC-derived endothelial cells and heterocellular in vitro models by controlled release of vascular endothelial growth factor. | 2021 Sep |
3 |
| 3 |
33754901 | Targeting regulation of the tumour microenvironment induces apoptosis of breast cancer cells by an affinity hemoperfusion adsorbent. | 2021 Dec |
2 |
| 4 |
33771558 | VEGF and VEGFR2 bind to similar pH-sensitive sites on fibronectin, exposed by heparin-mediated conformational changes. | 2021 Jan-Jun |
3 |
| 5 |
33822474 | Effect of heparinization on promoting angiogenesis of decellularized kidney scaffolds. | 2021 Oct |
1 |
| 6 |
34006633 | Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders. | 2021 May 25 |
1 |
| 7 |
34088930 | Investigation of the mechanisms of VEGF-mediated compensatory lung growth: the role of the VEGF heparin-binding domain. | 2021 Jun 4 |
1 |
| 8 |
34769095 | Complexation of CXCL12, FGF-2 and VEGF with Heparin Modulates the Protein Release from Alginate Microbeads. | 2021 Oct 28 |
2 |
| 9 |
31606923 | Poly(ε-caprolactone)/keratin/heparin/VEGF biocomposite mats for vascular tissue engineering. | 2020 Feb |
1 |
| 10 |
31998886 | Multifunctional coatings combining bioactive peptides and affinity-based cytokine delivery for enhanced integration of degradable vascular grafts. | 2020 Mar 17 |
2 |
| 11 |
32024165 | Nano-in-Micro Dual Delivery Platform for Chronic Wound Healing Applications. | 2020 Feb 1 |
1 |
| 12 |
32064767 | Heparin/poly-l-lysine nanoplatform with growth factor delivery for surface modification of cardiovascular stents: The influence of vascular endothelial growth factor loading. | 2020 Jun |
1 |
| 13 |
32420975 | Posterior reversible encephalopathy syndrome in an oncological normotensive patient: evidence for a pathogenic role of concomitant low magnesium serum levels and chemotherapy treatment. | 2020 May 11 |
1 |
| 14 |
32458960 | Interaction of vascular endothelial growth factor and heparin quantified by single molecule force spectroscopy. | 2020 Jun 11 |
3 |
| 15 |
32688092 | Effects of controlled dual growth factor delivery on bone regeneration following composite bone-muscle injury. | 2020 Sep 15 |
1 |
| 16 |
32885899 | Vascular endothelial growth factor sustained delivery augmented cell therapy outcomes of cardiac progenitor cells for myocardial infarction. | 2020 Dec |
1 |
| 17 |
33396366 | Molecular Targeting of VEGF with a Suramin Fragment-DOCA Conjugate by Mimicking the Action of Low Molecular Weight Heparins. | 2020 Dec 31 |
4 |
| 18 |
33463282 | Engineering a Self-Assembling Leucine Zipper Hydrogel System with Function-Specific Motifs for Tissue Regeneration. | 2020 May 11 |
2 |
| 19 |
30056611 | First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors. | 2019 Feb |
2 |
| 20 |
30821921 | Osteogenic Effects of VEGF-Overexpressed Human Adipose-Derived Stem Cells with Whitlockite Reinforced Cryogel for Bone Regeneration. | 2019 May |
2 |
| 21 |
31284097 | Co-immobilization of CD133 antibodies, vascular endothelial growth factors, and REDV peptide promotes capture, proliferation, and differentiation of endothelial progenitor cells. | 2019 Sep 15 |
2 |
| 22 |
31508535 | Branch retinal artery occlusion in the untreated contralateral eye following aflibercept injections during heparin treatment: Possible contribution of a heparin-induced thrombocytopenia-like condition. | 2019 Dec |
2 |
| 23 |
31601651 | Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH. | 2019 Nov 15 |
3 |
| 24 |
29030736 | N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors. | 2018 Feb |
1 |
| 25 |
29095088 | VEGF-A121a binding to Neuropilins - A concept revisited. | 2018 May 4 |
1 |
| 26 |
29254059 | Use of heparinized bacterial cellulose based scaffold for improving angiogenesis in tissue regeneration. | 2018 Feb 1 |
3 |
| 27 |
29346400 | The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation. | 2018 |
2 |
| 28 |
29441779 | Molecularly Imprinted Nanocavities Capable of Ligand-Binding Domain and Size/Shape Recognition for Selective Discrimination of Vascular Endothelial Growth Factor Isoforms. | 2018 Mar 23 |
1 |
| 29 |
29689163 | Heparin Functionalized Injectable Cryogel with Rapid Shape-Recovery Property for Neovascularization. | 2018 Jun 11 |
2 |
| 30 |
29730577 | The effects of biomimetically conjugated VEGF on osteogenesis and angiogenesis of MSCs (human and rat) and HUVECs co-culture models. | 2018 Jul 1 |
1 |
| 31 |
29738889 | Molecular dynamics-based model of VEGF-A and its heparin interactions. | 2018 Jun |
3 |
| 32 |
29923498 | Interactions of methacryloylated gelatin and heparin modulate physico-chemical properties of hydrogels and release of vascular endothelial growth factor. | 2018 Jul 19 |
1 |
| 33 |
29956017 | Heparin impairs angiogenic signaling and compensatory lung growth after left pneumonectomy. | 2018 Nov |
2 |
| 34 |
30539834 | Role of dalteparin sodium on the growth of cancer cells and tumor-associated angiogenesis in A549 human lung cancer cell line and grafted mouse model. | 2018 Dec |
1 |
| 35 |
33445338 | Vascular Endothelial Growth Factor Incorporated Multilayer Film Induces Preangiogenesis in Endothelial Cells. | 2018 May 14 |
1 |
| 36 |
27323268 | Further Support for ECM Control of Receptor Trafficking and Signaling. | 2017 Jan |
1 |
| 37 |
28181209 | Heparin modification of a biomimetic bone matrix modulates osteogenic and angiogenic cell response in vitro. | 2017 Feb 9 |
3 |
| 38 |
28316275 | * Central Growth Factor Loaded Depots in Bone Tissue Engineering Scaffolds for Enhanced Cell Attraction. | 2017 Aug |
1 |
| 39 |
30920532 | Controlled Release of Vascular Endothelial Growth Factor from Heparin-Functionalized Gelatin Type A and Albumin Hydrogels. | 2017 Oct 9 |
4 |
| 40 |
26773314 | Extracellular Matrix Stiffness Controls VEGF Signaling and Processing in Endothelial Cells. | 2016 Sep |
1 |
| 41 |
26794266 | In vivo vascularization of MSC-loaded porous hydroxyapatite constructs coated with VEGF-functionalized collagen/heparin multilayers. | 2016 Jan 22 |
1 |
| 42 |
26928466 | Growth factors-loaded stents modified with hyaluronic acid and heparin for induction of rapid and tight re-endothelialization. | 2016 May 1 |
2 |
| 43 |
26931056 | Pulp regeneration in a full-length human tooth root using a hierarchical nanofibrous microsphere system. | 2016 Apr 15 |
4 |
| 44 |
26980324 | Single-step synthesis of heparin-doped polypyrrole nanoparticles for delivery of angiogenic factor. | 2016 Apr |
4 |
| 45 |
27097314 | Circulating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells. | 2016 |
3 |
| 46 |
27196997 | Heparin-Based Coacervate of FGF2 Improves Dermal Regeneration by Asserting a Synergistic Role with Cell Proliferation and Endogenous Facilitated VEGF for Cutaneous Wound Healing. | 2016 Jun 13 |
1 |
| 47 |
27459086 | The effect of heparinized decellularized scaffolds on angiogenic capability. | 2016 Dec |
2 |
| 48 |
27566697 | Modulation of factors involved in placental haemostasis and angiogenesis by low-molecular-weight-heparins. | 2016 Nov |
1 |
| 49 |
27895888 | In situ formation of poly(vinyl alcohol)-heparin hydrogels for mild encapsulation and prolonged release of basic fibroblast growth factor and vascular endothelial growth factor. | 2016 Jan-Dec |
5 |
| 50 |
25256819 | Tailoring of the dopamine coated surface with VEGF loaded heparin/poly-L-lysine particles for anticoagulation and accelerate in situ endothelialization. | 2015 Jun |
2 |